Fig. 2: Single-cell analysis of the manifestations of disulfidptosis in pan-cancer.
From: Pan-cancer analysis uncovered the prognostic and therapeutic value of disulfidptosis
The expression patterns for SLC7A11, GLRX, GLRX2, GLRX3, and GLRX5 of malignant cells, immune cells, and stromal cells in (A) CHOL, (B) HNSC, (C) LIHC, (D) MCC, (E) NSCLC, and (F) PAAD. GLRX glutaredoxin, GLRX2 glutaredoxin 2, GLRX3 glutaredoxin 3, GLRX5 glutaredoxin 5, CHOL Cholangiocarcinoma, HNSC Head and Neck Cancer, LIHC Liver Cancer, MCC Merkel Cell Carcinoma, NSCLC Nonsmall-Cell Lung Cancer, PAAD Pancreatic Cancer.
